Christopher Cole, an executive officer with the US Food and Drug Administration (FDA), who is the head of the agency's Countermeasures Initiative, told a Project Veritas reporter that vaccine companies, like Pfizer for example, pay the agency hundreds of millions of dollars a year to keep reviewers that will approve their products.